We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Allergan Warned for Misleading Lumigan Promotion
Allergan Warned for Misleading Lumigan Promotion
September 16, 2005
Allergan has received an FDA warning letter for disseminating misleading promotional materials for its ocular treatment Lumigan.